Free Trial

Dyne Therapeutics (DYN) SEC Filings & 10K Form

Dyne Therapeutics logo
$8.17 +0.34 (+4.34%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$8.27 +0.10 (+1.27%)
As of 04/17/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Dyne Therapeutics SEC Filings

DateFilerForm TypeView
04/15/2025
6:34 AM
Dyne Therapeutics (Filer)
Form DEF 14A
04/15/2025
6:35 AM
Dyne Therapeutics (Filer)
Form DEFA14A
04/15/2025
6:38 AM
Dyne Therapeutics (Filer)
Form ARS
04/01/2025
3:31 PM
Dyne Therapeutics (Issuer)
Lucera Erick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/27/2025
6:31 AM
Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/20/2025
3:08 PM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
3:07 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:08 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:09 PM
Cox John (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/05/2025
3:10 PM
Dyne Therapeutics (Subject)
Kerr Douglas (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
6:25 AM
Dyne Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2025
6:35 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2025
6:20 AM
Dyne Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
11:22 AM
Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM
Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
02/12/2025
8:28 AM
Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
02/03/2025
4:07 PM
Dyne Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SCHEDULE 13G
01/29/2025
3:15 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2025
5:56 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2024
7:40 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
7:41 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/11/2024
3:18 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:19 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/11/2024
3:20 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/22/2024
3:06 PM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/18/2024
6:42 PM
Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
4:31 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2024
3:40 PM
Dyne Therapeutics (Subject)
Incerti Carlo (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM
Dyne Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:32 PM
Atlas Venture Fund XI, L.P. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
9:28 AM
Dyne Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
Form SC 13G
11/14/2024
8:27 AM
Deep Track Capital, LP (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/14/2024
6:00 AM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Filed by)
Form SC 13G/A
11/14/2024
5:34 AM
Dyne Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/12/2024
8:55 AM
Dyne Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G
11/08/2024
4:31 PM
BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
11/04/2024
9:20 AM
Dyne Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/22/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
2:24 PM
BlackRock, Inc. (Filed by)
Dyne Therapeutics (Subject)
Form SC 13G/A
10/03/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits... (Ad)

Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining stocks like most gold analyst CFAs, I decided to visit every significant gold mine I could. 10+ site visits later, I've confirmed my theory... That the most profitable mines share three specific characteristics. When you find all three together, the returns can be staggering.

Go here to learn about my Top Four picks for the coming bull mania.
09/24/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:51 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/19/2024
3:52 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2024
3:20 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:21 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:23 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:24 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/18/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:36 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:26 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:28 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:31 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:34 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
3:13 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:13 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:13 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:05 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/06/2024
3:22 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
3:34 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
4:42 PM
Cox John (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
5:14 PM
Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
5:16 PM
Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
5:20 PM
Dyne Therapeutics (Issuer)
Friedl-Naderer Johanna (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/03/2024
5:22 PM
Dyne Therapeutics (Issuer)
Kerr Douglas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
6:16 AM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
3:05 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:26 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:27 PM
Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:27 PM
Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
3:28 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
3:13 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:08 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:10 PM
Dyne Therapeutics (Subject)
McNeill Jonathan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:11 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:12 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
4:15 PM
Dyne Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
4:05 PM
Dyne Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2024
3:37 PM
Dyne Therapeutics (Subject)
Forbion Capital Fund IV Cooperatief U.A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2024
8:00 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4/A
06/24/2024
7:41 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2024
8:45 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:41 PM
Dyne Therapeutics (Issuer)
Farwell Wildon (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:42 PM
Beskrovnaya Oxana (Reporting)
Dyne Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:28 PM
Dyne Therapeutics (Issuer)
Scalzo Richard William (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:34 PM
Dyne Therapeutics (Issuer)
McNeill Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
6:34 PM
Dyne Therapeutics (Issuer)
HIGH SUSANNA GATTI (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
‘Wheels Are Falling Off’ the U.S. Stock Market (Ad)

The last time the U.S. economy looked like this, stocks didn't move for 16 years... And many investors lost 80% of their wealth in real terms. But before you touch any of your holdings – or buy anything – please review my latest warning about the U.S. stock market. It's free to watch.

Click here to view my new presentation now.
06/11/2024
3:32 PM
Dyne Therapeutics (Subject)
Farwell Wildon (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:33 PM
Dyne Therapeutics (Subject)
HIGH SUSANNA GATTI (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/10/2024
3:36 PM
Dyne Therapeutics (Subject)
Scalzo Richard William (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Lubner David Charles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Rhodes Jason P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
HURWITZ EDWARD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Kersten Dirk (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Incerti Carlo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2024
4:10 PM
Dyne Therapeutics (Issuer)
Stehman-Breen Catherine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:DYN) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners